Part 3 Amendments to secondary legislation

1. 8Amendment to the Medical Devices Regulations 2002
2. 9Amendment to regulation 2 (interpretation) in relation to Great Britain
3. 10Amendment to regulation 2 (interpretation) in relation to Northern Ireland
4. 11Amendment to regulation 2A (medical devices which are qualifying Northern Ireland goods)
5. 12Amendment to regulation 3ZA (revocation, transitional and saving provisions in respect of Regulation (EU) 2017/745)
6. 13Amendment to regulation 4T (references in other legislation to Directives 90/385, 93/42 and 98/79)
7. 14Revocation of regulation 19B (requirement to appoint a UK responsible person for general medical devices)
8. 15Revocation of regulation 21C (requirement to appoint a UK responsible person for active implantable medical devices)
9. 16Amendment to regulation 34A (approval requirement for coronavirus test devices)
10. 17New regulation 34D (exemption for coronavirus test devices in conformity with Regulation (EU) 2017/746 and Regulation (EU) 2022/1107)
11. 18Amendment to regulation 44 (registration of persons placing in vitro diagnostic medical devices on the market or for performance evaluation)
12. 19Revocation of regulation 44ZA (requirement to appoint a UK responsible person for placing in vitro diagnostic medical devices on the market or for performance evaluation)
13. 20Amendment to the Blood Safety and Quality Regulations 2005
14. 21Amendment to the Human Tissue (Quality and Safety for Human Application) Regulations 2007
15. 22Amendment to the Legislative and Regulatory Reform (Regulatory Functions) Order 2007
16. 23Amendment to the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Regulations 2012
17. 24Amendment to the Waste Electrical and Electronic Equipment Regulations 2013
18. 25Amendment to the Economic Growth (Regulatory Functions) Order 2017
19. 26Amendment to the Market Surveillance (Northern Ireland) Regulations 2021